Login / Signup

Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy.

Fatima AmorAi Vu HongGuillaume CorreMathilde SansonLaurence SuelStephanie BlaieLaurent ServaisThomas VoitIsabelle RichardDavid Israeli
Published in: Journal of cachexia, sarcopenia and muscle (2021)
This investigation supports that cholesterol metabolism and the mevalonate pathway are potential therapeutic targets in DMD.
Keyphrases
  • duchenne muscular dystrophy
  • low density lipoprotein
  • muscular dystrophy
  • human health